Medicine & Life Sciences
HIV Protease Inhibitors
100%
Facilitative Glucose Transport Proteins
89%
Glucose
77%
Protease Inhibitors
51%
Insulin Resistance
40%
3-hydroxy-3-methylglutaryl-coenzyme A lyase
34%
Ritonavir
34%
Indinavir
32%
Trehalose
27%
Lyases
27%
Deoxyglucose
27%
Liver Regeneration
25%
Dilated Cardiomyopathy
23%
Insulin
21%
Liver
20%
Cysteine
20%
Adipocytes
19%
2-N-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine
18%
Homeostasis
17%
Lopinavir
16%
Antimalarials
15%
Atazanavir Sulfate
14%
Glucose Transporter Type 4
13%
3-hydroxy-3-methylglutaryl-coenzyme A
13%
3-hydroxy-3-methylglutaryldithio-coenzyme A
13%
Monosaccharide Transport Proteins
12%
2-butynoyl-coenzyme A
12%
HIV-Associated Lipodystrophy Syndrome
11%
Protein Isoforms
11%
HIV
11%
Plasmodium falciparum
11%
Heart Failure
11%
Rodentia
11%
Parasites
11%
KT 362
11%
Pharmaceutical Preparations
11%
Enzymes
10%
deoxyxylulose phosphate
10%
HIV Infections
10%
Autophagy
10%
Fats
10%
Mutagenesis
10%
Complementary DNA
9%
Organism Cloning
9%
Solute Carrier Proteins
9%
acipimox
8%
Therapeutics
8%
DegP protease
8%
Glucagon-Like Peptide 1
8%
Adipose Tissue
8%
Chemical Compounds
Glucose
56%
HIV Protease Inhibitor
43%
Insulin Derivative
20%
Ritonavir
20%
Protease Inhibitor
19%
Indinavir
17%
3-Hydroxy-3-Methylglutaryl-CoA
16%
Cysteine
16%
Coenzyme A
12%
Protein
11%
Kinact
9%
Enzyme Activity
9%
Peroxisome Proliferator
8%
Rosiglitazone
8%
Peptide
7%
Metabolic
7%
Anionic Phospholipid
7%
Lipid
7%
Resistance
6%
Thiol
6%
Trehalose
6%
Ablation
5%
Antagonist
5%
Atazanavir
5%
Mutation
5%
Sulfonate
5%
Fat
5%
Solute
5%
